ROEBUCK FOOD GROUP PLC
("Roebuck" or "the Company", AIM: RFG)
Result of Extraordinary General Meeting
23 January 2025
Roebuck Food Group plc (AIM: RFG) a group focused on growth and innovation within the food and agribusiness sectors ("the Company" or "Roebuck") held an Extraordinary General Meeting earlier today to seek approval for the conditional agreement, announced on 13 December 2024, to acquire shareholdings in Glasport Bio Ltd and Glasport Rumen Tech Ltd ("the Acquisition") and the associated placing and subscription. The resolutions to approve the Acquisition and the placing and subscription, proposed at today's extraordinary general meeting of the Company, was duly passed and the new Ordinary Shares comprised in the placing and subscription have been allotted and issued, subject to Admission to AIM ("Admission") tomorrow 24 January 2025.
Admission will take place tomorrow, 24 January 2025, and completion of the Acquisition is planned to take place on 31 January 2025.
Following Admission, those with an interest in 3% or more of the Company's issued share capital, as understood by the Company, will be:
Premier Miton Group plc
Sean O'Driscoll 7.66%
EDCCU UC 6.62%
Nanook Investments Ltd 6.5%
Estate of Ted O'Neill decd 4.8%
T.B. Mantor AS 3.74%
Premier Miton plc's interest will be separately notified.
Following Admission, the holdings of Ordinary Shares in the Company in which the directors (persons discharging managerial responsibilities) will have an interest will be:
Kieran Mahon 2,613,074 shares (2.6%)
Sean Savage 1,628,121 shares (1.6%)
Aidan Hughes 950,370 shares (0.9%)
The directors of the Company accept responsibility for this announcement.
Enquiries:
Roebuck Food Group plc
Aidan Hughes, Deputy Chairman Telephone: + 44 1293 862 498
Davy (Nomad)
Anthony Farrell Telephone: + 353 1 679 6363
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.